Abstract

BackgroundWho should provide the values of health states in economic evaluations of health technologies has long been the subject of debate. This study examined and compared the relative importance of the EQ-5D five dimensions, using both patient-reported values and general population tariffs, among patients with chronic diseases in South Korea and also assessed the pattern of the discrepancy between patient and general population values by type of chronic diseases.MethodsData were taken from the 2013 Korea Health Panel survey. This analysis focused on adult patients with chronic diseases (n = 3216). Patient-reported EQ-5D profiles and visual analogue scale (VAS) values were used to assess the relative importance of the EQ-5D five dimensions among these patients, using a linear regression model. The relative importance of the EQ-5D dimensions was then compared to the EQ-5D tariffs elicited from the general population. The relative magnitude of the discrepancies between patient and general population values was also assessed by type of chronic diseases.ResultsAnxiety/depression and pain/discomfort appeared to have the largest impact on the self-rated patient VAS, which fairly contrasted with the general population model. In addition, a further regression analysis showed that the discrepancy between patient and general population values varied with the type of chronic diseases. The greatest discrepancy between the two was found in patients with diseases of the blood and blood-forming organs, neoplasms and diseases of the digestive system.ConclusionsThese analyses revealed differences in the relative weights attached to the EQ-5D dimensions between patient groups and the general population, particularly in those ‘non-tangible’ dimensions. These differences consequently led to greater discrepancies between patient and general population values in certain patient groups, which can have significant implications for resource allocation decisions in South Korea.

Highlights

  • Who should provide the values of health states in economic evaluations of health technologies has long been the subject of debate

  • The findings further suggest that the relative difference between patient and general population preferences varies with the type of chronic diseases, which implies that the use of general population preferences could disadvantage certain patient groups because their

  • It is possible to make a direct comparison only between the relative weights – not the absolute weights - of the EQ-5D dimensions given by patients and the general population. Despite these limitations, this study provides a glimpse of what dimensions of health patients with chronic diseases in South Korea consider more problematic

Read more

Summary

Introduction

Who should provide the values of health states in economic evaluations of health technologies has long been the subject of debate. There are, a lot of issues in measuring costs and QALYs, which can have significant implications for resource allocation decisions. One of those critical issues would be whose preferences should count when valuing health states and thereby calculating QALYs, which has long been the subject of debate [4, 5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call